CDKN2A and cancer: Increased expression of p16ink4a, a tumor suppressor protein, is a preprogrammed response decreasing proliferative capacities of stem cells to alleviate the increase in cancer risk with age [96–100], thus setting the paradigm of balancing senescence and cancer risk as mentioned above.